ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Q: What does CUSIP 82835W108 represent in this 13F holders report?

CUSIP 82835W108 is the security identifier for SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

92 institutional investors reported SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 82835W108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 99,255,583
Total 13F shares: 55,071,412
Share change: +1,651,559
Total reported value: $368,976,724
Put/Call ratio: 52%
Price per share: $6.70
Number of holders: 92
Value change: +$11,246,123
Number of buys: 62
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 82835W108?
CUSIP 82835W108 identifies SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 82835W108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	11%	11,077,927	$72,117,305	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	8.8%	8,740,887	$56,903,174	—	31 Mar 2023	13F
FMR LLC	13F	Company	5.1%	5,088,253	$33,124,526	—	31 Mar 2023	13F
SR ONE CAPITAL MANAGEMENT, LP	13F	Company	4%	4,012,903	$26,123,999	—	31 Mar 2023	13F
Rubric Capital Management LP	13F	Company	3.5%	3,480,712	$22,659,435	—	31 Mar 2023	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3%	3,009,678	$19,593,004	—	31 Mar 2023	13F
K2 PRINCIPAL FUND, L.P.	13F	Company	2.7%	2,686,490	$17,489,051	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	2%	2,006,451	$13,061,996	—	31 Mar 2023	13F
Nextech Invest Ltd.	13F	Company	1.9%	1,910,029	$12,434,289	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	1.7%	1,697,637	$11,051,617	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	1.1%	1,118,565	$7,281,859	—	31 Mar 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.8%	793,587	$5,166,251	—	31 Mar 2023	13F
Nicholas Investment Partners, LP	13F	Company	0.76%	755,622	$4,919,099	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.6%	600,000	$3,906,000	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.41%	409,463	$2,665,604	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.41%	403,604	$2,627,462	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.34%	334,259	$2,176,026	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	330,600	$2,152,000	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.32%	312,954	$2,037,331	—	31 Mar 2023	13F
ROYCE & ASSOCIATES LP	13F	Company	0.31%	303,900	$1,978,389	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.3%	295,271	$1,922,214	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.28%	280,329	$1,824,942	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	249,412	$1,624,000	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.25%	246,989	$1,607,898	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.22%	220,800	$1,437,408	—	31 Mar 2023	13F
Tejara Capital Ltd	13F	Company	0.21%	207,555	$1,351,183	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.2%	196,504	$1,279,241	—	31 Mar 2023	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.18%	183,287	$1,193,198	—	31 Mar 2023	13F
Vontobel Holding Ltd.	13F	Company	0.17%	169,732	$1,104,955	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.15%	153,532	$999,493	—	31 Mar 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.15%	149,915	$975,947	—	31 Mar 2023	13F
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	0.14%	140,351	$913,685	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.14%	137,450	$894,800	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.14%	135,684	$883,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.13%	129,191	$841,033	—	31 Mar 2023	13F
Resolute Capital Asset Partners LLC	13F	Company	0.12%	120,000	$781,000	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.11%	111,981	$728,996	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.1%	99,606	$648,436	—	31 Mar 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.08%	77,369	$503,672	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.07%	71,970	$468,524	—	31 Mar 2023	13F
Legal & General Group Plc	13F	Company	0.07%	64,543	$420,175	—	31 Mar 2023	13F
Informed Momentum Co LLC	13F	Company	0.06%	62,798	$408,815	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.05%	53,381	$347,510	—	31 Mar 2023	13F
Janney Montgomery Scott LLC	13F	Company	0.05%	50,243	$327,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	44,776	$291,491	—	31 Mar 2023	13F
CAXTON ASSOCIATES LP	13F	Company	0.04%	43,169	$281,030	—	31 Mar 2023	13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	13F	Company	0.04%	41,766	$272,000	—	31 Mar 2023	13F
Jonathan Piazza	3/4/5	Chief Financial Officer	— mixed-class rows	156,608 mixed-class rows	$261,878	—	02 May 2022	3/4/5
MARSHALL WACE, LLP	13F	Company	0.04%	39,428	$256,676	—	31 Mar 2023	13F
Jump Financial, LLC	13F	Company	0.04%	38,090	$247,966	—	31 Mar 2023	13F

Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q2 2023

As of 30 Jun 2023, ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,071,412 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, FMR LLC, SR ONE CAPITAL MANAGEMENT, LP, RA CAPITAL MANAGEMENT, L.P., Rubric Capital Management LP, BlackRock Inc., BAKER BROS. ADVISORS LP, Nextech Invest Ltd., and VANGUARD GROUP INC. This page lists 92 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.